| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/16/2009 | WO2009087356A1 Host range change phage |
| 07/16/2009 | WO2008093009A8 Method for preparing bacteriophages modified by the insertion of random sequences in the screening proteins of said bacteriophages |
| 07/16/2009 | WO2008017870A8 Attenuated polio viruses |
| 07/16/2009 | WO2002083925A3 Papaya ringspot virus genes |
| 07/16/2009 | US20090181931 Antiviral activity of cidofovir against oncolytic viruses |
| 07/16/2009 | US20090181446 Method for propagating influenza virus |
| 07/16/2009 | US20090181051 N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 07/16/2009 | US20090181044 Novel Flavivirus antigens |
| 07/16/2009 | US20090180994 Oncolytic virus therapy |
| 07/16/2009 | US20090180975 Polynucleotide Fragments Of An Infectious Human Endogenous Retrovirus |
| 07/16/2009 | CA2711334A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/15/2009 | EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 07/15/2009 | EP2078083A1 A novel canine influenza virus and vaccine therefore |
| 07/15/2009 | EP2077867A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system |
| 07/15/2009 | CN100513560C Method for virus propagation |
| 07/15/2009 | CN100513559C Novel vaccinia virus strain, vaccinia live attenuated vaccine and preparation method thereof |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560278 A recombinant mammalian cell that expresses a mammalian adenovirus E1 functional protein and comprises a porcine circovirus genome |
| 07/14/2009 | US7560118 Attenuated dengue virus comprising mutations in the NS3 gene |
| 07/14/2009 | US7560116 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 07/14/2009 | US7560113 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 07/09/2009 | WO2009085912A1 Methods and compositions for immunizing pigs against porcine circovirus |
| 07/09/2009 | WO2009085178A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors |
| 07/09/2009 | WO2009085172A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| 07/09/2009 | WO2009083210A1 Replication-defective arenavirus vectors |
| 07/09/2009 | WO2009083202A1 Parvovirus having a cpg-enriched genome useful for cancer therapy |
| 07/09/2009 | WO2009008921A9 Influenza b viruses with reduced sensitivity to neuraminidase inhibitors |
| 07/09/2009 | WO2008034388A8 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof |
| 07/09/2009 | US20090176784 Anti-infective agents and uses thereof |
| 07/09/2009 | US20090176660 Engineered Baculoviruses and Their Use |
| 07/09/2009 | US20090176203 Mutant HSV, Materials and Methods for Generation of Mutant HSV |
| 07/09/2009 | US20090176200 Modified Human Hepatitis C Virus Genomic RNA That can be Autonomously Replicated |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175909 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175908 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175907 Multi Plasmid System For The Production Of Influenza Virus |
| 07/09/2009 | US20090175906 Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof |
| 07/09/2009 | US20090175899 Recombinant rsv virus expression systems and vaccines |
| 07/09/2009 | US20090175898 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175896 CAT Allergen Conjugates and Uses Thereof |
| 07/09/2009 | US20090175889 Hiv vaccine |
| 07/09/2009 | CA2744910A1 Replication-defective arenavirus vectors |
| 07/09/2009 | CA2710889A1 Parvovirus having a cpg-enriched genome useful for cancer therapy |
| 07/09/2009 | CA2710356A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors |
| 07/09/2009 | CA2710247A1 Methods and compositions for immunizing pigs against porcine circovirus |
| 07/09/2009 | CA2710166A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| 07/08/2009 | EP2076603A2 A serum-free virus propagation platform for a virus vaccine candidate |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | CN100509842C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/07/2009 | USRE40832 An adenovirus type 36 (Ad-36) vaccine formualtion suitable for administration to a patient for reducing cholesterol and triglyceride level ( cause of obesity); killed Ad-36, an inactivated Ad-36, a protein or peptide sequence including an Ad-36 coat protein or fragment |
| 07/07/2009 | US7557199 Hepatitis C virus vaccine |
| 07/07/2009 | US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556940 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 07/07/2009 | US7556814 Antigen containing an attenuated strain of human immunodeficient virus; using psoralen and ultraviolet radiation |
| 07/07/2009 | US7556812 Purified polypeptide used for eliciting immune response against a West Nile virus associated disease |
| 07/07/2009 | CA2415990C Method for producing biologicals in protein-free culture |
| 07/02/2009 | WO2009080781A1 Process for clarifying cell homogenates |
| 07/02/2009 | WO2009080053A1 Efficient cell culture system for hepatitis c virus genotype 1a and 1b |
| 07/02/2009 | WO2009080052A1 Efficient cell culture system for hepatitis c virus genotype 6a |
| 07/02/2009 | WO2009030676A3 Pharmaceutical composition comprising a japanese encephalitis virus for vaccination of patients of at least 40 years of age |
| 07/02/2009 | US20090170953 Indentification of compounds that inhibit replication of human immunodeficiency virus |
| 07/02/2009 | US20090170846 Inhibitors of the hiv integrase enzyme |
| 07/02/2009 | US20090170794 Small interfering rnas that efficiently inhibit viral expression and methods of use thereof |
| 07/02/2009 | US20090170161 GDEP Enhancer Element and Use Thereof to Confer Retinal Specific Gene Expression |
| 07/02/2009 | US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof |
| 07/02/2009 | US20090170067 Simian tropic, recombinant human immunodeficiency-1 viruses |
| 07/02/2009 | US20090170063 Hcv rna having novel sequence |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169581 Stabilizing formulations for recombinant viruses |
| 07/02/2009 | US20090169580 Attenuated vaccines for non-segmented negative sense rna viruses |
| 07/02/2009 | US20090169579 Modified vaccinia Ankara virus avriant |
| 07/02/2009 | US20090169513 Expression of virus entry inhibitors and recombinant AAV therefor |
| 07/02/2009 | US20090169512 Clonal strain of attenuated vaccinia virus that can be used to prevent or treat small pox |
| 07/02/2009 | CA2710350A1 Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof |
| 07/01/2009 | EP2075006A1 Aquatic nervous necrosis virus (NNV) vaccine and manufacture method thereof |
| 07/01/2009 | EP2075003A1 Parvovirus having a CpG-enriched genome useful for cancer therapy |
| 07/01/2009 | EP2074140A2 Fibrillation-resistant insulin and insulin analogues |
| 07/01/2009 | EP2073818A2 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 07/01/2009 | EP1080216B1 Retroviral delivery system |
| 07/01/2009 | EP1025243B1 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS |
| 07/01/2009 | CN100506989C Mosaic infections bursal disease virus vaccines |
| 06/30/2009 | US7553668 transgenic plant; host cell; isolated nucleic acid molecule; nucleic acid sequences encoding the coat protein ; DNA expression vector; disease resistance |
| 06/30/2009 | US7553617 Fusion proteins of bacteriophage coat proteins, and bacteriophage particles are screened against receptors |
| 06/25/2009 | WO2009079308A2 Composition and method of use of sheep fab phage display library |
| 06/25/2009 | WO2009076824A1 Genes encoding major capsid protein l1 of human papilloma virus's |
| 06/25/2009 | WO2009076778A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 06/25/2009 | WO2009018964A3 System comprising bacteriophages and particles that contain active substances |
| 06/25/2009 | WO2008142479A3 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus |
| 06/25/2009 | US20090163368 Directed evolution using proteins comprising unnatural amino acids |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162918 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant |
| 06/25/2009 | US20090162834 Molecular sequence of swine retrovirus and methods of use |
| 06/25/2009 | US20090162831 human parvovirus |
| 06/25/2009 | US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| 06/25/2009 | US20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/25/2009 | US20090162395 Vaccine for rsv and mpv |
| 06/25/2009 | US20090162332 Methods and compositions for treating brain diseases |